The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression

British Journal of Cancer

Volumn 106, Issue 12, 2012, Pages 1901-1906

  Houthuijzen, J M ^a   Daenen, L G M ^a   Roodhart, J M L ^a   Voest, E E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

chemotherapy resistance; drug resistance; mesenchymal stem cells; tumour progression

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER RESISTANCE; DRUG SENSITIVITY; HEAD AND NECK CARCINOMA; HUMAN; LEUKEMIA; MEDICAL LITERATURE; MESENCHYMAL STEM CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; CELL DIFFERENTIATION; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; HUMANS; MESENCHYMAL STEM CELLS; NEOPLASTIC STEM CELLS; TUMOR MICROENVIRONMENT;

EID: 84862012508     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.201     Document Type: Review

References (30)

1. Balakrishnan K, Burger JA, Quiroga MP, Henneberg M, Ayres ML, Wierda WG, Gandhi V (2010) Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells. Blood 116: 1083-1091
2. Bian ZY, Li G, Gan YK, Hao YQ, Xu WT, Tang TT (2009) Increased number of mesenchymal stem cell-like cells in peripheral blood of patients with bone sarcomas. Arch Med Res 40: 163-168
3. Chen X, Armstrong MA, Li G (2006) Mesenchymal stem cells in immunoregulation. Immunol Cell Biol. 84: 413-421 (Pubitemid 44286034)
4. Dawson MR, Chae SS, Jain RK, Duda DG (2011) Direct evidence for lineagedependent effects of bone marrow stromal cells on tumor progression. Am J Cancer Res 1: 144-154
5. Hung SC, Pochampally RR, Chen SC, Hsu SC, Prockop DJ (2007) Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells. 25: 2363-2370 (Pubitemid 47480496)
6. Ishihara K, Murata M, Kaneniwa M, Saito H, Komatsu W, Shinohara K (2000) Purification of stearidonic acid (18:4(n-3)) and hexadecatetraenoic acid (16:4(n-3)) from algal fatty acid with lipase and medium pressure liquid chromatography. Biosci Biotechnol Biochem 64: 2454-2457
7. Iwamoto S, Mihara K, Downing JR, Pui CH, Campana D (2007) Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest 117: 1049-1057 (Pubitemid 46556761)
8. Jin L, Tabe Y, Konoplev S, Xu Y, Leysath CE, Lu H, Kimura S, Ohsaka A, Rios MB, Calvert L, Kantarjian H, Andreeff M, Konopleva M (2008) CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia CML cell migration to bone marrow stroma and promotes survival of quiescent CML cells. Mol Cancer Ther 7: 48-58
9. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563 (Pubitemid 47525152)
10. Kim SM, Lim JY, Park SI, Jeong CH, Oh JH, Jeong M, Oh W, Park SH, Sung YC, Jeun SS (2008) Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res 68: 9614-9623
11. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringdén O (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371: 1579-1586 (Pubitemid 351626841)
12. Lis R, Touboul C, Mirshahi P, Ali F, Mathew S, Nolan DJ, Maleki M, Abdalla SA, Raynaud CM, Querleu D, Al-Azwani E, Malek J, Mirshahi M, Rafii A (2011) Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12. Int J Cancer 128: 715-725
13. Loebinger MR, Kyrtatos PG, Turmaine M, Price AN, Pankhurst Q, Lythgoe MF, Janes SM (2009) Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 69: 8862-8867
14. Meads MB, Hazlehurst LA, Dalton WS (2008) The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res 14: 2519-2526
15. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Banerjee D (2008) Carcinoma-associated fibroblastlike differentiation of human mesenchymal stem cells. Cancer Res 68: 4331-4339
16. Patel SA, Meyer JR, Greco SJ, Corcoran KE, Bryan M, Rameshwar P (2010) Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol 184: 5885-5894
17. Qiao L, Xu Z, Zhao T, Zhao Z, Shi M, Zhao RC, Ye L, Zhang X (2008) Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res 18: 500-507 (Pubitemid 351498857)
18. Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D, Dazzi F (2007) Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 21: 304-310 (Pubitemid 46158124)
19. Reagan MR, Kaplan DR (2011) Concise review: Mesenchymal stem cell tumor-homing: detection methods in disease model systems. Stem Cells 29: 920-927
20. Ringe J, Strassburg S, Neumann K, Endres M, Notter M, Burmester GR, Kaps C, Sittinger M (2007) Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem 101: 135-146 (Pubitemid 46652579)
21. Roodhart JM, Daenen LG, Stigter EC, Prins HJ, Gerrits J, Houthuijzen JM, Gerritsen MG, Schipper HS. Backer MJ, van Amersfoort M, Vermaat JS, Moerer P, Ishihara K, Kalkhoven E, Beijnen JH, Derksen PW, Medema RH, Martens AC, Brenkman AB, Voest EE (2011) Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell 20: 370-383
22. Rouzer CA, Scott WA, Griffith OW, Hamill AL, Cohn ZA (1982) Arachidonic acid metabolism in glutathione-deficient macrophages. Proc Natl Acad Sci USA 79: 1621-1625 (Pubitemid 12113320)
23. Scherzed A, Hackenberg S, Froelich K, Kessler M, Koehler C, Hagen R, Radeloff A, Friehs G, Kleinsasser N (2011) BMSC enhance the survival of paclitaxel treated squamous cell carcinoma cells in vitro. Cancer Biol Ther 11: 349-357
24. Schlosser S, Dennler C, Schweizer R, Eberli D, Stein JV, Enzmann V, Giovanoli P, Erni D, Plock JA (2012) Paracrine effects of mesenchymal stem cells enhance vascular regeneration in ischemic murine skin. Microvasc Res 83(3): 267-275
25. Shome S, Dasgupta PS, Basu S (2012) Dopamine Regulates Mobilization of Mesenchymal Stem Cells during Wound Angiogenesis. PLoS One 7(2): e31682
26. Song C, Li G (2011) CXCR4 and matrix metalloproteinase-2 are involved in mesenchymal stromal cell homing and engraftment to tumors. Cytotherapy 13: 549-561
27. Teng IW, Hou PC, Lee KD, Chu PY, Yeh KT, Jin VX, Tseng MJ, Tsai SJ, Chang YS, Wu CS, Sun HS, Tsai KD, Jeng LB, Nephew KP, Huang TH, Hsiao SH, Leu YW (2011) Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res 71: 4653-4663
28. Valle-Prieto A, Conget PA (2010) Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells Dev 19: 1885-1893
29. Vianello F, Villanova F, Tisato V, Lymperi S, Ho KK, Gomes AR, Marin D, Bonnet D, Apperley J, Lam EW, Dazzi F (2010) Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis. Haematologica 95: 1081-1089
30. Whatley RE, Zimmerman GA, McIntyre TM, Prescott SM (1990) Lipid metabolism and signal transduction in endothelial cells. Prog Lipid Res 29: 45-63 (Pubitemid 120036505)